As we delve into the complex world of cancer biology, I’m thrilled to speak with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development. Ivan’s deep knowledge of technology and innovation in the industry offers unique insights into groundbreaking studies,
Introduction Imagine a world where life-saving cancer treatments, once out of reach due to exorbitant costs and lengthy production times, become accessible to patients in desperate need through groundbreaking innovations. CAR-T therapy, a revolutionary immunotherapy that modifies a patient's T
Imagine a world where detecting cancer is as simple as breathing into a device or collecting a urine sample at home, with results available almost instantly through a smartphone app, transforming the way we approach early diagnosis. This vision, once confined to science fiction, is rapidly becoming
What if the key to defeating some of humanity's most devastating diseases lies within the tiniest boundaries of human cells, invisible to the naked eye, and only accessible through advanced technology? Membrane proteins, the unsung heroes of cellular function, act as gatekeepers, controlling the
I'm thrilled to sit down with Ivan Kairatov, a distinguished expert in biopharma with a profound understanding of technological innovation and research in the field. Today, we’re diving into the groundbreaking advancements in biomedical imaging, specifically focusing on a pioneering project at the
Triple-negative breast cancer (TNBC) remains one of the most formidable challenges in oncology, characterized by its aggressive nature and lack of the three common receptors—estrogen, progesterone, and HER2—that many standard therapies target, leaving patients with limited treatment options and
